Digital Technology in Clinical Trials Conference
Need Approval in Order to Attend?
Download and fill out our in Person Justification Letter to demonstrate to your supervisor why this is a must-attend event.
DIA Additional Information
DIA How To
Regulatory Sprint Replay: Can We Develop an Agile Regulatory Decision Matrix for Digital Measurement?
Thursday, March 10, 2022 | 11:00AM – 12:00PM ET
FDA has issued a new draft guidance document on Digital Health Technologies for Remote Data Acquisition in Clinical Investigations and is accepting comments on the draft guidance until March 2022. This FDA guidance provides recommendations on the use of digital health technologies (DHTs) to acquire data from clinical investigation participants remotely.